My watch list
my.bionity.com  
Login  

Eric Fombonne



Eric Fombonne, MD, FRCP, (b. 1954, Paris, France) is a professor of psychiatry and an epidemiologist.  He directs the child psychiatry division at McGill University in Canada and the psychiatry department at the Montreal Children's Hospital, where he played a key role in the launch of its autism clinic.  Fombonne is also the Canada Research Chair in child psychiatry.  His research focuses on epidemiological investigations of childhood mental illness and related risk factors, with a particular focus on the epidemiology of autism.

Fombonne is a permanent member of a National Institute of Mental Health (NIMH) study section and has been appointed to a special National Institute of Health (NIH) advisory board for autism research programs. In October, 2002 he became the president of the Association of Child and Adolescent Psychiatry of Canada (APCAPC).

Contents

Research

Prior to his arrival in Canada, Fombonne was a researcher at the Institute of Psychiatry, King's College in London, United Kingdom, where he also worked as a child and adolescent psychiatrist at Maudsley Hospital. While there, he and his colleagues were credited with demonstrating that there is no epidemiological evidence of a link between the MMR vaccine with autism, as postulated by other researchers including Andrew Wakefield. A New Scientist article quotes Fombonne as saying "Trying to link this with MMR is complete nonsense."

One of the major studies conducted by Fombonne examined depression, which linked alcohol abuse to increased suicidal tendencies in boys, using data on 6,000 subjects.

At McGill University, Fombonne has consolidated the Autism Spectrum Disorder program in Montreal since his appointment there in 2001. He currently heads an autism research program directed at evaluating environmental risk factors, such as vaccines, and investigating genetic risks associated with the heritability of autism. He has also been involved in molecular genetic studies of clinical depression, and in long-term outcome studies of child and adolescent depression.

Does this mean there is an epidemic of PDD? Not at all. We believe the high rates we are seeing are the result of a combination of factors. With improved recognition of the symptoms, diagnosis of PDD is now being made more frequently and at an earlier age, thus increasing the number of children being diagnosed. More rigorous methods used in recent surveys have also improved our ability to find cases of PDD. The lower rates found in two of the most recent studies, for instance, most certainly reflect less sensitive case finding approaches.

— Eric Fombonne[1]

Autism epidemic

Fombonne has reported that the prevalence of autism is 68 per 10,000, or one in 147.

He attributes the apparent rise in autism cases to wider recognition of the condition, and argues that claims of an 'autism epidemic' are unfounded.[2] In 2001, he told the BBC "That rates in recent surveys are substantially higher than 30 years ago merely reflects the adoption of a much broader concept of autism, a recognition of autism among normally intelligent subjects and an improved identification of persons with autism."

Published works

Fombonne has written over 130 scientific reports in peer reviewed journals and 25 book chapters. He was associate editor of the Journal of Autism and Developmental Disorders from 1994 to 2003.

Family

Fombonne was married to Rebecca Fuhrer, chair of the joint Department of Epidemiology, Biostatistics and Occupational Health at McGill, and is the father of four boys, Jonathan, Daniel, Benjamin and Arthur.

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Eric_Fombonne". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE